Form 4: Clene Director Granted Stock Options

Clene Inc. Director Jonathon Gay was granted 4,790 stock options with an immediate vesting schedule under the company's 2020 Stock Plan.

Summary

• Jonathon Gay, a Director of Clene Inc. (CLNN), was granted 4,790 stock options.
• The options were granted on August 14, 2025, under the Clene Inc. Amended 2020 Stock Plan.
• Each option has an exercise price of $3.60 per share.
• The options vest immediately upon grant.
• The expiration date for these options is August 13, 2035.
• Following this transaction, Jonathon Gay beneficially owns 4,790 derivative securities directly.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a standard compensation practice, aligning the director's interests with the company's long-term performance, which is generally viewed as a neutral to slightly positive governance practice.

Positives

• The stock options vest immediately upon grant, providing immediate ownership rights.
• The long expiration date of August 13, 2035, offers a significant window for the director to exercise the options, aligning long-term interests.

Negatives

• The options do not provide immediate cash value and their ultimate value is dependent on the future stock price exceeding the exercise price of $3.60.

Risks

• The value of the stock options is subject to the volatility of Clene Inc.'s common stock price.
• Future exercise of these options could lead to minor dilution for existing shareholders, although the amount is small relative to the total shares outstanding.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing is a routine disclosure of director compensation and does not provide broader insights into industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Potential for alignment of director interests with shareholder value; minor potential for future dilution upon exercise of options.

Key Dates

Recommendation

This Form 4 filing reports a routine stock option grant to a director as part of their compensation. It does not contain information significant enough to alter an investment thesis or warrant a change in recommendation based solely on this disclosure.

Keywords

Clene Inc., CLNN, stock option, director compensation, equity grant, SEC Form 4, corporate governance